professional documents
home
Upload
docsters
Upload
CDER Forum for International Drug Regulatory Authorities September 25-28, 2006 CDER’s International Program Justina A. Molzon, M.S. Pharm., J.D. Associate Director for International Programs CDER, USFDA Thank you for coming and WELCOME! Overview Monday Tuesday Wednesday Thursday Applications and Review Application Review Compliance Pharmocovigilance and Generic Drugs Morning Sessions Welcome and Introduction Role of CDER Good Guidance Practices Good Review Practices Good Clinical Practice Good Manufacturing Practice Compliance Drug Safety Drug Marketing Lunch is on your own Lunch is on your own Lunch is on your own Lunch is on your own Afternoon Session Drug Review Process Training Reviewers Advisory Committees Group Photograph Discipline Panel Specialty Reviews Over-the-Counter Drugs Good Clinical Practice Good Manufacturing Practice Compliance Office of Generic Drugs CDER on the World Wide Web International Program Leveraging Activities ƒ WHO ƒ Consultations and review of documents ƒ Members of Technical Committees ƒ PAHO ƒ Pan American Network for Drug Regulatory Harmonization ƒ Lead for GMP and BA/BE Working Group and member of Drug Registration Working Group ƒ ICH ƒ Publication of ICH Guidances ƒ Current focus is implementation of CTD ƒ Global Cooperation Group- Regional Harmonization Initiatives ƒ PEPFAR ƒ President’s Emergency Plan for AIDs Relief International Program Leveraging Activities ƒ International visitors/training requests ƒ Coordinated with the agency’s Office of International Programs ƒ Prioritization of requests ƒ Kept to a minimum so won’t disrupt the review process and burden review staff ƒ Confidentiality issues of concern ƒ CDER Forum for International Drug Regulatory Authorities CDER Forum September 2005 CDER Forum March 2006 FDA’s International Program ƒ Office of International Programs ƒ Melinda Plaisier, Assistant Commissioner ƒ Walter Batts, Deputy Director ƒ Africa, Middle East, Asia/Pacific, Americas ƒ Bev Corey, Staff Director Matt Eckel, Staff Director ƒ Europe/Eurasia ƒ ƒ FDA’s International Working Group (IWG) ƒ Composed of OIP and Center representatives Introductions International Colleagues Please share … Your Name Your Country Your Position Key areas of interest in CDER Forum topics
flag this doc
109
0
not rated
0
5/9/2008
English
Preview

FDA A fillable

GovernmentDocs 5/4/2008 | 399 | 4 | 0 | legal
Preview

FDA Regulatory Pathway Annual FDA and the Changing

GovernmentDocs 5/4/2008 | 163 | 2 | 0 | legal
Preview

FDA Assistance to Industry

FDADocs 5/9/2008 | 138 | 1 | 0 | legal
Preview

FDA s Accomplishments in 2005

FDADocs 5/9/2008 | 89 | 0 | 0 | legal
Preview

FDA Receipt for Samples

FDADocs 5/9/2008 | 138 | 1 | 0 | legal
Preview

AFFIDAVIT IN TRANSIT FDA

FDADocs 5/9/2008 | 75 | 0 | 0 | legal
Preview

FDA Information Page

FDADocs 5/9/2008 | 103 | 0 | 0 | legal
Preview

FDA Field Inspections

FDADocs 5/5/2008 | 112 | 0 | 0 | legal
Preview

FDA Organizational Chart

FDADocs 5/8/2008 | 308 | 3 | 0 | legal
Preview

NOTICE OF FDA ACTION

FDADocs 5/9/2008 | 132 | 0 | 0 | legal
Preview

Irradiation of Food An FDA Perspective Packaging

FDADocs 5/8/2008 | 115 | 1 | 0 | legal
Preview

Irradiation of Food An FDA Perspective

GovernmentDocs 5/4/2008 | 135 | 2 | 0 | legal
Preview

Vaccine Safety An FDA Perspective

FDADocs 5/5/2008 | 106 | 3 | 0 | legal
Preview

FDA Forum handheld Doppler safety

FDADocs 5/9/2008 | 60 | 0 | 0 | legal
Preview

SPL at the FDA A Progress Report Lisa Stockbridge FDA

GovernmentDocs 5/4/2008 | 49 | 0 | 0 | legal
Preview

Pfizer DTC Hearing Abstract

FDADocs 5/12/2008 | 141 | 1 | 0 | legal
Preview

ROTARIX Rotavirus Vaccine Live Oral

FDADocs 5/12/2008 | 279 | 1 | 0 | legal
Preview

Section Pharmacological Research of VasoCleaner on Hyperlipidemia and Atherosclerosis

FDADocs 5/12/2008 | 157 | 1 | 0 | legal
Preview

Section Documents regarding a Chinese Patent of the herbal formuIation

FDADocs 5/12/2008 | 159 | 1 | 0 | legal
Preview

Section Toxicological tests of VasoCleaner in Mice and Rats

FDADocs 5/12/2008 | 109 | 2 | 0 | legal
Preview

June Pre Market Notification Letter

FDADocs 5/12/2008 | 122 | 0 | 0 | legal
Preview

Report on toxicity test of Xiwang capsule

FDADocs 5/12/2008 | 227 | 0 | 0 | legal
Preview

August letter to Christopher Weisberg P A

FDADocs 5/12/2008 | 181 | 0 | 0 | legal
Preview

Laboratoires Laphal DRD B P Allauch CEDEX France

FDADocs 5/12/2008 | 264 | 0 | 0 | legal
Preview

Transmittal Letter and July letter to Christopher Weisberg P A

FDADocs 5/12/2008 | 113 | 0 | 0 | legal
 
review this doc